APhA Patient-Centered Diabetes Care Practice Exam 2025 – Your Complete All-in-One Guide to Success!

Metabolic surgery is increasingly recognized as a beneficial intervention for adults with inadequately controlled type 2 diabetes, particularly among those with a higher body mass index (BMI). The threshold of 30 kg/m² is significant because it aligns with the growing body of clinical evidence suggesting that individuals with a BMI at this level, coupled with type 2 diabetes, may experience substantial improvements in glycemic control following surgical intervention.

Studies have shown that metabolic surgery, such as gastric bypass or sleeve gastrectomy, can lead to remission or significant improvement of diabetes in people who fall into this BMI category. This is particularly relevant for patients who have not achieved adequate blood glucose control through lifestyle modifications and pharmacotherapy alone.

The option of a BMI of 30 kg/m² reflects the understanding that even individuals who are classified as overweight (BMI ≥ 25 but < 30) may benefit from surgery, as metabolic pathways and weight-related complications in type 2 diabetes can be significantly impacted by the surgery. This recommendation takes into account both the potential health risks associated with diabetes and obesity, as well as the benefits that surgical interventions can provide in terms of weight loss and its subsequent effect on metabolic health.

Therefore, the rationale for considering metabolic surgery at the BMI threshold of